Menu

Source Legend
  • Human-provided

    Entered or confirmed by an authorized person.

  • Google

    Imported Google information.

  • Trial-derived

    Calculated or extracted directly from associated trial records.

  • AI-inferred

    A capability inferred from trial history.

  • AI-extracted

    An explicit statement extracted from an official source.

  • Public registry

    Information from a public registry.

  • Site record

    Information held in the site record.

Source: Site record. Nebraska Cancer Research Center

Claim This Site

Are you the site administrator? Claim this site to update information.

Basic Information

Site Overview

Source: Human-provided.

Nebraska Cancer Research Center is a clinical research facility in Lincoln, Nebraska, USA, that focuses on conducting clinical trials to evaluate cancer treatments and improve patient outcomes. Its research activities include studies investigating therapies for various cancers, including breast cancer, lung cancer, and head and neck cancer. The center supports patient recruitment and enrollment in clinical studies, contributing to the evaluation of investigational treatments and evidence-based cancer care

Business Status

Source: Google. OPEN

Business Category

Source: Google. Social services organization

Business Subcategory

Source: Google. Social services organization
Source: Trial-derived.
70Total Trials
Source: Trial-derived.
0Recruiting Trials
Source: Trial-derived.
32Active Trials
Source: Trial-derived.
33Completed Trials
Source: Trial-derived.
344Unique Conditions
Source: Trial-derived.
21Unique Sponsors

Affiliations

Conditions

Source: Trial-derived. Recurrent Squamous Cell Lung Carcinoma (8)Source: Trial-derived. Stage IV Squamous Cell Lung Carcinoma AJCC v7 (7)Source: Trial-derived. Recurrent Melanoma (5)Source: Trial-derived. Stage IIIC Cutaneous Melanoma AJCC v7 (4)Source: Trial-derived. Stage IV Cutaneous Melanoma AJCC v6 and v7 (4)Source: Trial-derived. Breast Adenocarcinoma (3)Source: Trial-derived. Breast Carcinoma (3)Source: Trial-derived. Recurrent Breast Carcinoma (3)

Sponsors

Source: Trial-derived. National Cancer Institute (NCI) (70)Source: Trial-derived. SWOG Cancer Research Network (16)Source: Trial-derived. Alliance for Clinical Trials in Oncology (8)Source: Trial-derived. NRG Oncology (6)Source: Trial-derived. ECOG-ACRIN Cancer Research Group (5)Source: Trial-derived. Cancer and Leukemia Group B (4)Source: Trial-derived. Canadian Cancer Trials Group (3)Source: Trial-derived. NCIC Clinical Trials Group (3)

Imaging & Diagnostics

Imaging and diagnostic capabilities inferred from trial participation

Source: AI-inferred. Electrocardiography (lead count not stated)
Source: AI-inferred. CT Scan
Source: AI-inferred. Echocardiography
Source: AI-inferred. SPECT / nuclear medicine
Source: AI-inferred. MRI
Source: AI-inferred. X-Ray
Source: AI-inferred. Mammography
Source: AI-inferred. Ultrasound

Laboratory & Biospecimens

Laboratory and biospecimen capabilities inferred from trial participation

Source: AI-inferred. Clinical laboratory testing
Source: AI-inferred. Histology / pathology
Source: AI-inferred. Specimen packaging and shipment
Source: AI-inferred. Biobanking
Source: AI-inferred. Sequencing / genomics
Source: AI-inferred. PCR / molecular
Source: AI-inferred. Circulating tumour DNA testing
Source: AI-inferred. Flow Cytometry

Research Pharmacy & Investigational Product

Investigational-product capabilities inferred from trial participation

Source: AI-inferred. Hazardous / cytotoxic drug handling

Clinical Procedures

Clinical procedures inferred from trial participation

Source: AI-inferred. Intravenous infusion administration
Source: AI-inferred. Tumour tissue biopsy (guidance not stated)
Source: AI-inferred. Radiation therapy
Source: AI-inferred. Surgery / operating room
Source: AI-inferred. Bone marrow biopsy
Source: AI-inferred. Endoscopy / colonoscopy
Source: AI-inferred. Intensity-modulated radiation therapy
Source: AI-inferred. Blood transfusion service

Accessibility & Parking

Accessibility Features

Source: Google. Wheelchair accessible entrance
Source: Google. Wheelchair accessible parking lot

Additional Capabilities

Other capabilities inferred from trial participation

Source: AI-inferred. CD4 lymphocyte enumeration
Source: AI-inferred. Electronic trial enrollment system
Source: AI-inferred. Protein electrophoresis and immunofixation
Source: AI-inferred. Tumour response imaging (modality not specified)
Source: AI-inferred. Behavioral health or psychiatric support
Source: AI-inferred. Circulating tumour cell collection and enumeration
Source: AI-inferred. Conventional cytogenetic analysis (karyotyping/FISH)
Source: AI-inferred. Cytogenetic analysis (karyotype/FISH)